secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0001477932-25-004721
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx shareholders approve authorized share increase to 325M; all director nominees elected
--------------------------------------------------------------------------------

- Authorized common shares increased from 175M to 325M effective June 18, 2025, via Certificate of Second Amendment.
- All eight director nominees elected with ~35-36M votes for each; about 14.7M broker non-votes.
- Ratification of Sadler, Gibb & Associates as auditor passed with 51.3M votes for, 330k against.
- Non-binding advisory vote on named executive officer compensation passed with 34.4M for, 2.3M against.
- Charter amendment proposal passed with 49.5M votes for, 1.8M against, and 385k abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793225004721/0001477932-25-004721-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793225004721/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-004721

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer